Language
中文
English
0086-571-86912261
sales@newcanbio.com
3671025517
Structure
Popular keywords:
153186-10-8
63593-03-3
123402-21-1
Home
Products
Service
Custom Synthesis
Commercial production
Analytical Services
International Trade
Company Profile
Company Profile
ContactUs
Contact Information
News
News
Product category
Basic
Carbohydrate
Nucleoside
Nucleotide
Phosphoramidite
Impurity
Others
Brand Category
NewCanBio
Home
>
Product Catalog
>
All
All
Mode
Molecular Weight
All
0-100
100-200
>200
Brand
All
NewCan Bio
NewCan
NC186667
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-dodecanoate
254449-30-4
Inquiry
NC186668
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate
254449-29-1
Inquiry
NC186669
1-Deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-α-L-talofuranuronamide
254449-28-0
Inquiry
NC186670
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-hexadecanoate
254449-27-9
Inquiry
NC186671
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-pentadecanoate
254449-26-8
Inquiry
NC186672
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-tetradecanoate
254449-25-7
Inquiry
NC186673
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-dodecanoate
254449-24-6
Inquiry
NC186674
SQ 641
254449-23-5
Inquiry
NC186675
1-Deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-5-O-[(2S,4R)-6-[[[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]amino]carbonyl]-3,4-dihydro-4-hydroxy-2H-pyran-2-yl]-3-O-methyl-α-L-talofuranuronamide
254449-22-4
Inquiry
NC186676
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-
254449-21-3
Inquiry
NC186677
1-Deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-α-L-talofuranuronamide
254449-20-2
Inquiry
NC186678
Adenosine, 2′-deoxy-3′,5′-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-N-(triphenylphosphoranylidene)-
254445-53-9
Inquiry
NC186679
Adenosine, 2′-Se-phenyl-2′-seleno-3′,5′-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-N-(triphenylphosphoranylidene)-
254445-48-2
Inquiry
NC186680
2′-Deoxyadenylyl-(3′→5′)-2′-deoxyguanylyl-(3′→5′)-2′-deoxyadenylyl-(3′→5′)-thymidylyl-(3′→5′)-2′-deoxyadenylyl-(3′→5′)-2′-deoxyadenosine
254435-81-9
Inquiry
NC186681
Uridine, 2′,5′-dideoxy-, 3′-acetate
25442-50-6
Inquiry
NC186682
Uracil, 1-β-D-xylofuranosyl-, 3′-(phenyl methylphosphonate)
25442-49-3
Inquiry
NC186683
Uracil, 1-(2-O-trityl-β-D-xylofuranosyl)-
25442-48-2
Inquiry
NC186684
Uracil, 1-(3-deoxy-3-iodo-2-O-trityl-β-D-xylofuranosyl)-
25442-47-1
Inquiry
NC186685
1-[3-O-(Hydroxymethylphosphinyl)-β-D-arabinofuranosyl]-2,4(1H,3H)-pyrimidinedione
25442-46-0
Inquiry
NC186686
Uridine, 3′-(hydrogen methylphosphonate)
25442-45-9
Inquiry
9114
9115
9116
9117
9118
9119
9120
9121
9122
9123
Competitive price
Fast logistics
Technical support
Spot stock
Service
Feedback
Top